We serve Chemical Name:4-fluoro-2-methylsulfonylpyridine CAS:1207613-69-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-fluoro-2-methylsulfonylpyridine
CAS.NO:1207613-69-1
Synonyms:4-fluoro-2-(methylsulfonyl)pyridine;qc-7106
Molecular Formula:C6H6FNO2S
Molecular Weight:175.18100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:1.361
Index of Refraction:
PSA:55.41000
Exact Mass:175.01000
LogP:1.70500
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-fluoro-2-(methylsulfonyl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,qc-7106 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,qc-7106 Use and application,qc-7106 technical grade,usp/ep/jp grade.
Related News: However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 4-fluoro-2-methylsulfonylpyridine manufacturer Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System. 4-fluoro-2-methylsulfonylpyridine supplier He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address ��the issue of the human-to-human transmission of the coronavirus.�� 4-fluoro-2-methylsulfonylpyridine vendor Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend. 4-fluoro-2-methylsulfonylpyridine factory However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial.
